The publisher and authors would like to draw the reader's attention to two errors in the following article:
Brzeczko AW, Leech R, Stark JG. The advent of a new pseudoephedrine product to combat methamphetamine abuse. Am J Drug Alcohol Abuse 2013;39:284–290.
On page 284, “Pseudoephedrine and methamphetamine molecules are chemically different by a single oxygen atom. Two popular chemical reduction reactions are used to remove this oxygen atom” is more accurately described by “Pseudoephedrine and methamphetamine molecules are chemically different by a hydroxyl group (OH). Two popular chemical reduction reactions are used to remove this hydroxyl group.”
On page 289, reference 1 is incorrectly cited and is replaced by:
Desoxyn®, CII (methamphetamine hydrochloride tablets, USP), Recordati Rare Diseases, 2013 Available from: www.recordatirarediseases.com/products/us-product/desoxyn%C2%AE-cii-methamphetamine-hydrochloride-tablets-usp [last accessed 12 Sep 2013].